BPI has established a modern manufacturing facility for the production of oral cytotoxic solid dosages, to meet the growing need for anti-cancer products.
Fully segregated manufacturing suites are strictly designed following International guidelines to protect the personnel and environment and to produce efficient lifesaving drugs.
- High-level Containment Compliant Manufacturing Suites
- Isolator Technology
- Advanced and Dedicated Air Handling System and HEPA Filtration
- State -of-the-art Closed Transfer System Equipment
- Specialized Quality Control Laboratories